<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03877588</url>
  </required_header>
  <id_info>
    <org_study_id>INT-91/16</org_study_id>
    <nct_id>NCT03877588</nct_id>
  </id_info>
  <brief_title>Nutritional Status in Retroperitoneal Sarcoma.</brief_title>
  <acronym>NOVA</acronym>
  <official_title>Perioperative Nutritional and Hemodinamic Support in Retroperitoneal Sarcoma Patients. A Phase II Prospective Feasibility Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective feasibility study of perioperative nutrition in patients affected by primary
      retroperitoneal sarcoma
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of our study was to investigate the feasibility of a prehabilitation policy to optimize
      protein energetic reserves in a group of patients affected by primary localized RPS,
      candidate to a multiple organ resection surgery, as well as the feasibility of a standardized
      nutritional postoperative caloric target and its adequacy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 6, 2016</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">June 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of Adherence to protocol</measure>
    <time_frame>15 days</time_frame>
    <description>Rate of adherence to prescribed oral nutritional support</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Retroperitoneal Sarcoma</condition>
  <condition>Malnutrition</condition>
  <arm_group>
    <arm_group_label>Primary retroperitoneal sarcoma</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All eligible patients are screened in preoperative phase, at least 30 days before surgery, for presence of protein energetic malnutrition (PEM). PEM is defined according to biochemical and physiological parameters (Table). 3 class of PEM are identified: no PEM, mild PEM and serious PEM. Different nutritional oral supplements are provided according to the degree of malnutrition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral Nutritional Support</intervention_name>
    <description>Preoperative oral nutritional support is provided according to malnutrition grade</description>
    <arm_group_label>Primary retroperitoneal sarcoma</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - every patient with retroperitoneal sarcoma scheduled for surgery

        Exclusion Criteria:

          -  chronic renal failure

          -  diabetes mellitus

          -  emergency surgery

          -  physical status classification system ASA&gt;3

          -  any contraindication to arterial catheter in Femoral artery for PICCO hemodynamic
             monitoring
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 14, 2019</study_first_submitted>
  <study_first_submitted_qc>March 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2019</study_first_posted>
  <last_update_submitted>March 14, 2019</last_update_submitted>
  <last_update_submitted_qc>March 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcoma</mesh_term>
    <mesh_term>Malnutrition</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 13, 2020</submitted>
    <returned>January 23, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

